ReviewSubstance abuse2022
Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice.
Review in Substance abuse, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic review of patient-reported outcome measures for opioid use disorder recovery.Addiction (Abingdon, England) · 2026Pooled it
- Addiction recovery is more than abstinence-our metrics should be too.Lancet regional health. Americas · 2026Article
- Elevating Patient Voices to Improve Opioid Use Disorder Quality Measurement: A Survey Protocol.Substance use & addiction journal · 2026Article
- A scoping review of healthcare effectiveness data and information set (HEDIS) substance use disorder measures.Annals of medicine · 2025Article
- Implementation of screening and assessment tools for diagnosing opioid use disorder: A systematic review.Drug and alcohol dependence reports · 2025Review
- Nurse workforce change and metropolitan medically underserved areas in the United States.BMC health services research · 2025Article
- Smartphone App-Based Contingency Management and Opioid Use Disorder Treatment Outcomes.JAMA network open · 2024Article
- Implementation and adaptation of clinical quality improvement opioid measures.Healthcare (Amsterdam, Netherlands) · 2024Article
- "It's Like A Partnership": Exploring the Primary Care Experiences and Patient-Defined Goals of People Who Use Drugs.Journal of general internal medicine · 2024Article
- Growing importance of high-volume buprenorphine prescribers in OUD treatment: 2009-2018.Drug and alcohol dependence · 2024Observational
- Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022.Pain medicine (Malden, Mass.) · 2023Article
- Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives.Journal of general internal medicine · 2023Article
- Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder.Journal of addiction medicineArticle
- Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process.Journal of addiction medicineArticle
- Evidence on Buprenorphine Dose Limits: A Review.Journal of addiction medicineReview
- "I'm Clean and Sober, But Not Necessarily Free": Perceptions of Buprenorphine Among Patients in Long-Term Treatment.Substance abuseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.